NCT01106599 2016-11-02A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0623 in Patients With Locally Advanced or Metastatic Solid TumorsGenentech, Inc.Phase 1 Completed61 enrolled